
CAS 536748-46-6
:Eribaxaban
Description:
Eribaxaban is an anticoagulant medication that belongs to the class of direct factor Xa inhibitors. It is designed to prevent thrombus formation by selectively inhibiting factor Xa, an essential enzyme in the coagulation cascade. This inhibition disrupts the conversion of prothrombin to thrombin, thereby reducing the formation of fibrin clots. Eribaxaban is characterized by its oral bioavailability, allowing for convenient administration. The substance exhibits a relatively short half-life, which necessitates careful dosing to maintain therapeutic levels. Its pharmacokinetics are influenced by factors such as renal function and hepatic metabolism, making patient-specific considerations important in its use. Eribaxaban is primarily investigated for its potential in treating and preventing venous thromboembolism and other thrombotic disorders. As with other anticoagulants, monitoring for bleeding risks is crucial during treatment. Overall, Eribaxaban represents a significant advancement in anticoagulant therapy, offering a targeted approach to managing coagulation disorders.
Formula:C24H22ClFN4O4
InChI:InChI=1S/C24H22ClFN4O4/c1-34-18-13-21(30(14-18)24(33)27-16-7-5-15(25)6-8-16)23(32)28-20-10-9-17(12-19(20)26)29-11-3-2-4-22(29)31/h2-12,18,21H,13-14H2,1H3,(H,27,33)(H,28,32)/t18-,21-/m1/s1
InChI key:InChIKey=QQBKAVAGLMGMHI-WIYYLYMNSA-N
SMILES:C(NC1=C(F)C=C(C=C1)N2C(=O)C=CC=C2)(=O)[C@@H]3N(C(NC4=CC=C(Cl)C=C4)=O)C[C@H](OC)C3
Synonyms:- (2R,4R)-4-Methoxypyrrolidine-1,2-dicarboxylic acid 1-[(4-chlorophenyl)amide] 2-[[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)phenyl]amide]
- PD 348292
- Eribaxaban
- 1,2-Pyrrolidinedicarboxamide, N1-(4-chlorophenyl)-N2-[2-fluoro-4-(2-oxo-1(2H)-pyridinyl)phenyl]-4-methoxy-, (2R,4R)-
- (2R,4R)-N1-(4-Chlorophenyl)-N2-[2-fluoro-4-(2-oxo-1(2H)-pyridinyl)phenyl]-4-methoxy-1,2-pyrrolidinedicarboxamide
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 2 products.
Eribaxaban
CAS:Eribaxaban (PD348292) is an orally available factor Xa inhibitor for the prevention and treatment of venous thromboembolism.Formula:C24H22ClFN4O4Purity:98.99% - 99.13%Color and Shape:SolidMolecular weight:484.91

